Detalles de la búsqueda
1.
OpenSAFELY: The impact of COVID-19 on azathioprine, leflunomide and methotrexate monitoring, and factors associated with change in monitoring rate.
Br J Clin Pharmacol
; 2024 Apr 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38589944
2.
The impact of COVID-19 on medication reviews in English primary care. An OpenSAFELY-TPP analysis of 20 million adult electronic health records.
Br J Clin Pharmacol
; 2024 Mar 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-38531661
3.
Challenges in Estimating the Effectiveness of COVID-19 Vaccination Using Observational Data.
Ann Intern Med
; 176(5): 685-693, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37126810
4.
Overall and cause-specific hospitalisation and death after COVID-19 hospitalisation in England: A cohort study using linked primary care, secondary care, and death registration data in the OpenSAFELY platform.
PLoS Med
; 19(1): e1003871, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35077449
5.
Ethnic differences in SARS-CoV-2 infection and COVID-19-related hospitalisation, intensive care unit admission, and death in 17 million adults in England: an observational cohort study using the OpenSAFELY platform.
Lancet
; 397(10286): 1711-1724, 2021 05 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33939953
6.
Recording of 'COVID-19 vaccine declined': a cohort study on 57.9 million National Health Service patients' records in situ using OpenSAFELY, England, 8 December 2020 to 25 May 2021.
Euro Surveill
; 27(33)2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35983770
7.
CHALLENGES IN ESTIMATING THE EFFECTIVENESS OF 2 DOSES OF COVID-19 VACCINE BEYOND 6 MONTHS IN ENGLAND.
Am J Epidemiol
; 193(1): 227-231, 2024 Jan 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37656609
8.
Weight trends amongst adults with diabetes or hypertension during the COVID-19 pandemic: an observational study using OpenSAFELY.
Br J Gen Pract
; 2024 Feb 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38296356
9.
Comparative effectiveness of two- and three-dose COVID-19 vaccination schedules involving AZD1222 and BNT162b2 in people with kidney disease: a linked OpenSAFELY and UK Renal Registry cohort study.
Lancet Reg Health Eur
; : 100636, 2023 May 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-37363796
10.
First dose COVID-19 vaccine coverage amongst adolescents and children in England: an analysis of 3.21 million patients' primary care records in situ using OpenSAFELY.
Wellcome Open Res
; 8: 70, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37346822
11.
Factors associated with COVID-19 vaccine uptake in people with kidney disease: an OpenSAFELY cohort study.
BMJ Open
; 13(1): e066164, 2023 01 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-36720568
12.
Comparative effectiveness of nirmatrelvir/ritonavir versus sotrovimab and molnupiravir for preventing severe COVID-19 outcomes in non-hospitalised high-risk patients during Omicron waves: observational cohort study using the OpenSAFELY platform.
Lancet Reg Health Eur
; 34: 100741, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37927438
13.
Comparative effectiveness of sotrovimab and molnupiravir for preventing severe COVID-19 outcomes in patients on kidney replacement therapy: observational study using the OpenSAFELY-UKRR and SRR databases.
Clin Kidney J
; 16(11): 2048-2058, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37915915
14.
Comparative effectiveness of BNT162b2 versus mRNA-1273 covid-19 vaccine boosting in England: matched cohort study in OpenSAFELY-TPP.
BMJ
; 380: e072808, 2023 03 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-36921925
15.
OpenSAFELY NHS Service Restoration Observatory 2: changes in primary care clinical activity in England during the COVID-19 pandemic.
Br J Gen Pract
; 73(730): e318-e331, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37068964
16.
Changes in COVID-19-related mortality across key demographic and clinical subgroups in England from 2020 to 2022: a retrospective cohort study using the OpenSAFELY platform.
Lancet Public Health
; 8(5): e364-e377, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37120260
17.
Trends, variation, and clinical characteristics of recipients of antiviral drugs and neutralising monoclonal antibodies for covid-19 in community settings: retrospective, descriptive cohort study of 23.4 million people in OpenSAFELY.
BMJ Med
; 2(1): e000276, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36936265
18.
Waning effectiveness of BNT162b2 and ChAdOx1 covid-19 vaccines over six months since second dose: OpenSAFELY cohort study using linked electronic health records.
BMJ
; 378: e071249, 2022 07 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-35858698
19.
Safety of COVID-19 vaccination and acute neurological events: A self-controlled case series in England using the OpenSAFELY platform.
Vaccine
; 40(32): 4479-4487, 2022 07 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-35715350
20.
OpenSAFELY NHS Service Restoration Observatory 1: primary care clinical activity in England during the first wave of COVID-19.
Br J Gen Pract
; 72(714): e63-e74, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34750105